Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial. Combes A, Saura O, Nesseler N, Lebbah S, et al. JAMA 2026;335:60-69.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Combes A, Saura O, Nesseler N, Lebbah S, et al. Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial. JAMA 2026;335:60-69.
PMID: 41324946